 |
Forest Laboratories Inc. - PharmaVitae Profile |
Company Profile |
Global |
24/11/08 |
£3,010.00 |
| Introduction This analysis examines the historical and forecast performance for Forest in the prescription pharmaceutical sector. The profile encompasses global company strategy, portfolio and |
 |
Iomai Corporation - Corporate and Strategic Assessment Report - Company Strategy, SWOT Analysis |
Company Profile |
Global |
06/11/08 |
£265.00 |
| Introduction Iomai is a biopharmaceutical company focused on the research and development of vaccines and immune system stimulants based on its TCI technology for the prevention and treatment of |
 |
Japan Tobacco Inc.-Company Report |
Company Profile |
Global |
08/01/09 |
£399.00 |
| Private Company Reports provide up to date insight into the structure and operations of privately-held pharmaceutical, biotechnology and biomedical companies. Scope of the report: Accessing |
 |
Medestea Internazionale S.p.A.-Company Report |
Company Profile |
Global |
08/01/09 |
£399.00 |
| Private Company Reports provide up to date insight into the structure and operations of privately-held pharmaceutical, biotechnology and biomedical companies. Scope of the report: Accessing |
 |
Acologix, Inc.-Company Report |
Company Profile |
Global |
08/01/09 |
£399.00 |
| Private Company Reports provide up to date insight into the structure and operations of privately-held pharmaceutical, biotechnology and biomedical companies. Scope of the report: Accessing |
 |
AFLOFARM-Company Report |
Company Profile |
Global |
08/01/09 |
£399.00 |
| Private Company Reports provide up to date insight into the structure and operations of privately-held pharmaceutical, biotechnology and biomedical companies. Scope of the report: Accessing |
 |
Alizyme plc-Company Report |
Company Profile |
Global |
08/01/09 |
£399.00 |
| Private Company Reports provide up to date insight into the structure and operations of privately-held pharmaceutical, biotechnology and biomedical companies. Scope of the report: Accessing |
 |
Amin Pharmaceutical Company-Company Report |
Company Profile |
Global |
08/01/09 |
£399.00 |
| Private Company Reports provide up to date insight into the structure and operations of privately-held pharmaceutical, biotechnology and biomedical companies. Scope of the report: Accessing |
 |
Apeiron Biologics-Company Report |
Company Profile |
Global |
08/01/09 |
£399.00 |
| Private Company Reports provide up to date insight into the structure and operations of privately-held pharmaceutical, biotechnology and biomedical companies. Scope of the report: Accessing |
 |
ArmaGen Technologies, Inc.-Company Report |
Company Profile |
Global |
08/01/09 |
£399.00 |
| Private Company Reports provide up to date insight into the structure and operations of privately-held pharmaceutical, biotechnology and biomedical companies. Scope of the report: Accessing |
 |
Avantogen Limited (formerly Australian Cancer Technology Limited)-Company Report |
Company Profile |
Global |
08/01/09 |
£399.00 |
| Private Company Reports provide up to date insight into the structure and operations of privately-held pharmaceutical, biotechnology and biomedical companies. Scope of the report: Accessing |
 |
Beijing SL Pharmaceutical Co., Ltd-Company Report |
Company Profile |
Global |
08/01/09 |
£399.00 |
| Private Company Reports provide up to date insight into the structure and operations of privately-held pharmaceutical, biotechnology and biomedical companies. Scope of the report: Accessing |
 |
BioInvent International AB-Company Report |
Company Profile |
Global |
08/01/09 |
£399.00 |
| Private Company Reports provide up to date insight into the structure and operations of privately-held pharmaceutical, biotechnology and biomedical companies. Scope of the report: Accessing |
 |
BIOTON S.A-Company Report |
Company Profile |
Global |
08/01/09 |
£399.00 |
| Private Company Reports provide up to date insight into the structure and operations of privately-held pharmaceutical, biotechnology and biomedical companies. Scope of the report: Accessing |
 |
British Biologicals-Company Report |
Company Profile |
Global |
08/01/09 |
£399.00 |
| Private Company Reports provide up to date insight into the structure and operations of privately-held pharmaceutical, biotechnology and biomedical companies. Scope of the report: Accessing |
 |
Cellzome AG-Company Report |
Company Profile |
Global |
08/01/09 |
£399.00 |
| Private Company Reports provide up to date insight into the structure and operations of privately-held pharmaceutical, biotechnology and biomedical companies. Scope of the report: Accessing |
 |
Chongqing-Yaoyou-Pharmaceutical-Company Report |
Company Profile |
Global |
08/01/09 |
£399.00 |
| Private Company Reports provide up to date insight into the structure and operations of privately-held pharmaceutical, biotechnology and biomedical companies. Scope of the report: Accessing |
 |
ConjuChem Inc.-Company Report |
Company Profile |
Global |
08/01/09 |
£399.00 |
| Private Company Reports provide up to date insight into the structure and operations of privately-held pharmaceutical, biotechnology and biomedical companies. Scope of the report: Accessing |
 |
DiaMedica Inc.-Company Report |
Company Profile |
Global |
08/01/09 |
£399.00 |
| Private Company Reports provide up to date insight into the structure and operations of privately-held pharmaceutical, biotechnology and biomedical companies. Scope of the report: Accessing |
 |
Dynapharm (M) Sdn. Bhd.-Company Report |
Company Profile |
Global |
08/01/09 |
£399.00 |
| Private Company Reports provide up to date insight into the structure and operations of privately-held pharmaceutical, biotechnology and biomedical companies. Scope of the report: Accessing |
 |
ENT Technologies PTY LTD-Company Report |
Company Profile |
Global |
08/01/09 |
£399.00 |
| Private Company Reports provide up to date insight into the structure and operations of privately-held pharmaceutical, biotechnology and biomedical companies. Scope of the report: Accessing |
 |
FAES FARMA-Company Report |
Company Profile |
Global |
08/01/09 |
£399.00 |
| Private Company Reports provide up to date insight into the structure and operations of privately-held pharmaceutical, biotechnology and biomedical companies. Scope of the report: Accessing |
 |
Fresenius Kabi AG-Company Report |
Company Profile |
Global |
08/01/09 |
£399.00 |
| Private Company Reports provide up to date insight into the structure and operations of privately-held pharmaceutical, biotechnology and biomedical companies. Scope of the report: Accessing |
 |
Genexine Co., Ltd.-Company Report |
Company Profile |
Global |
08/01/09 |
£399.00 |
| Private Company Reports provide up to date insight into the structure and operations of privately-held pharmaceutical, biotechnology and biomedical companies. Scope of the report: Accessing |
 |
GP Pharm-Company Report |
Company Profile |
Global |
08/01/09 |
£399.00 |
| Private Company Reports provide up to date insight into the structure and operations of privately-held pharmaceutical, biotechnology and biomedical companies. Scope of the report: Accessing |